查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541375

2024-2032 年导管导引溶栓设备市场报告（依输送模式、适应症（肺栓塞、深部静脉栓塞、深部静脉栓塞）、最终用户和地区划分）

Catheter-Directed Thrombolysis Devices Market Report by Delivery Mode, Indication (Pulmonary Embolism, Deep Vein Thrombosis, Stroke, and Others), End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球导管定向溶栓设备市场规模达3.763亿美元。慢性病盛行率不断上升、消费者对早期发现和治疗肺栓塞重要性的认识不断提高以及医疗基础设施的显着改善是推动市场的一些主要因素。

导管导引溶栓装置是用于治疗体内血管内形成的血栓的先进医疗工具。这些装置专门设计用于将溶栓剂直接输送到凝块部位，溶解阻塞并恢復血流。此手术涉及在 X 光或超音波等影像引导下将导管（一根细的柔性管）插入受影响的血管。透过导管，溶解血栓的药物直接输送到凝块或註入凝块周围的血管中。导管引导溶栓已被证明在快速恢復血流、降低长期併发症的风险以及保留受影响器官或肢体的功能方面非常有效。它通常用于治疗深部静脉血栓 (DVT)、肺栓塞、週边动脉闭塞和其他血管疾病等疾病。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球导管定向血栓溶解设备市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依交付模式

  • 直接输送至血块
    • 市场趋势
    • 市场预测
  • 将医疗设备放置在血栓部位
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依迹象

  • 肺栓塞（PE）
    • 市场趋势
    • 市场预测
  • 深部静脉血栓 (DVT)
    • 市场趋势
    • 市场预测
  • 中风
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 印尼
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AngioDynamics, Inc
    • Boston Scientific Corporation
    • Inari Medical, Inc.
    • iVascular, SLU
    • Medtronic Plc
    • Penumbra, Inc.
    • Straub Medical AG (Becton, Dickinson and Company)
    • Teleflex Incorporated
    • Thrombolex Inc.
Product Code: SR112024A4990

The global catheter-directed thrombolysis devices market size reached US$ 376.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 581.3 Million by 2032, exhibiting a growth rate (CAGR) of 4.8% during 2024-2032. The growing prevalence of chronic diseases, the rising consumer awareness about the importance of early detection and treatment of pulmonary embolism, and significant improvements in the healthcare infrastructure are some of the major factors propelling the market.

Catheter-directed thrombolysis devices are advanced medical tools used to treat blood clots that form within the body's blood vessels. These devices are specifically designed to deliver thrombolytic agents directly to the site of the clot, where they work to dissolve the obstruction and restore blood flow. The procedure involves the insertion of a catheter, a thin, flexible tube, into the affected blood vessel under image guidance, such as an X-ray or ultrasound. Through the catheter, a clot-dissolving medication is delivered directly to the clot or infused into the blood vessel surrounding it. Catheter-directed thrombolysis has proven to be highly effective in quickly restoring blood flow, reducing the risk of long-term complications, and preserving the functionality of the affected organ or limb. It is commonly used to treat conditions, such as deep vein thrombosis (DVT), pulmonary embolism, peripheral arterial occlusions, and other vascular disorders.

Catheter-Directed Thrombolysis Devices Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global catheter-directed thrombolysis devices market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on delivery mode, indication and end user.

Breakup by Delivery Mode:

Directly Delivery to Blood Clot

Positioning Medical Device at Clot Site

The report has provided a detailed breakup and analysis of the market based on the delivery mode. This includes directly delivery to blood clot and positioning medical device at clot site.

Directly delivering thrombolytic agents to the blood clot is a significant delivery mode in catheter-directed thrombolysis. In this approach, the catheter is inserted directly into the blood vessel where the clot is located, ensuring precise and targeted administration of the thrombolytic medication. This method allows for a concentrated and localized action, effectively dissolving the clot and restoring blood flow without affecting other parts of the circulatory system.

On the other hand, the positioning of a medical device at the clot site is a delivery mode in catheter-directed thrombolysis. These devices may include mechanical thrombectomy devices, such as rotating catheters or aspiration systems. This delivery mode is particularly beneficial in cases where direct infusion of thrombolytic agents may not be suitable, such as in large or resistant clots, or when the risk of bleeding from medication is a concern.

Breakup by Indication:

Pulmonary Embolism (PE)

Deep Vein Thrombosis (DVT)

Stroke

Others

The report has provided a detailed breakup and analysis of the market based on the indication. This includes pulmonary embolism (PE), deep vein thrombosis (DVT), stroke, and others.

Pulmonary embolism is a critical medical condition and a leading indication segment in the catheter-directed thrombolysis market. PE occurs when a blood clot, often originating from deep veins in the legs, travels through the bloodstream and lodges in the arteries of the lungs, causing a potentially life-threatening obstruction. Catheter-directed thrombolysis is a highly effective treatment for PE as it rapidly dissolves the clot and restores blood flow to the lungs.

On the other hand, deep vein thrombosis is another major indication segment in the catheter-directed thrombolysis market. DVT occurs when a blood clot forms in a deep vein, most commonly in the legs. Catheter-directed thrombolysis for DVT not only alleviates symptoms and reduces the risk of severe complications but also plays a crucial role in preventing long-term issues, such as chronic venous insufficiency. As DVT is a prevalent and potentially serious condition, the demand for catheter-directed thrombolysis devices remains high in the market.

Breakup by End User:

Hospitals

Others

Hospitals represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, and others. According to the report, hospitals accounted for the largest market share.

Hospitals serve as central hubs for medical care and are equipped with advanced facilities, skilled healthcare professionals, and specialized departments, making them ideal settings for performing catheter-directed thrombolysis procedures. The complexity and critical nature of vascular diseases and thrombotic disorders often require a multidisciplinary approach involving interventional radiologists, vascular surgeons, cardiologists, and other medical specialists available in a hospital environment. These medical professionals collaborate to diagnose and treat patients with conditions, including pulmonary embolism, deep vein thrombosis, peripheral arterial occlusions, and other vascular obstructions. Moreover, hospitals have access to state-of-the-art imaging technologies, such as fluoroscopy, ultrasound, and computed tomography (CT), which aid in precise catheter navigation and real-time visualization of the clot during the procedure. Additionally, hospitals maintain a comprehensive range of medical equipment and devices, including the latest catheter-directed thrombolysis technologies, to ensure optimal patient care.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

Australia

South Korea

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (United States and Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Russia and the rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, Indonesia and rest of Asia-Pacific), Latin America (Brazil, Mexico and rest of Latin America) and the Middle East and Africa. According to the report, North America represents the leading market.

The market in North America is primarily being driven due to advanced healthcare infrastructure, a well-established medical device industry, and a high prevalence of vascular diseases in the region. The region's strong emphasis on healthcare research and innovation has led to the development of cutting-edge catheter-directed thrombolysis devices, further driving their adoption.

The market in Asia Pacific is witnessing an increase in the aging population, which is more susceptible to vascular conditions, further augmenting the demand for these devices. The presence of leading medical device manufacturers and ongoing research and development efforts also contribute to the growth of the market in the Asia Pacific. With a combination of a vast patient pool, improving healthcare facilities, and a focus on technological advancements, the Asia Pacific region is expected to maintain its dominant position in the catheter-directed thrombolysis devices market.

Competitive Landscape:

Companies in the market are heavily investing in research and development to improve the design, efficacy, and safety of their catheter-directed thrombolysis devices. They are focused on creating innovative technologies and drug delivery mechanisms to enhance the clot-dissolving process and minimize the risk of bleeding complications. Moreover, leading players are conducting clinical trials to gather evidence of safety and efficacy and obtaining regulatory approvals from health authorities to market their devices globally. These processes helped establish the credibility and compliance of their products. Additionally, several companies are providing training and educational programs to healthcare professionals to ensure they had the necessary skills and knowledge to use catheter-directed thrombolysis devices effectively and safely. To stay competitive, major companies are launching new catheter-directed thrombolysis devices or upgraded existing ones. These products were often designed to be more user-friendly, precise, and capable of achieving better patient outcomes.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

AngioDynamics, Inc.

Boston Scientific Corporation

Inari Medical, Inc.

iVascular, S.L.U

Medtronic Plc

Penumbra, Inc.

Straub Medical AG (Becton, Dickinson, and Company)

Teleflex Incorporated

Thrombolex Inc.

Recent Developments:

In February 2023, Teleflex Incorporated launched New Arrow(R) VPS Rhythm(R) DLX Device and NaviCurve(TM) Stylet. It provides real-time catheter tip location information by using the patient's cardiac electrical activity. The device is also available with an optional integrated ultrasound featuring a Catheter-to-Vessel ratio tool that promotes standardization in vessel measurement. This device works in concert with the Arrow(R) PICC preloaded with the NaviCurve(TM) Stylet, providing innovative tip navigation/location technologies.

In January 2023, Penumbra Inc. launched the Lightning Flash(TM). It features Penumbra's novel Lightning Intelligent Aspiration technology, now with dual clot detection algorithms. Together with innovative catheter engineering, Lightning Flash is designed to quickly remove large blood clots in the body, including venous thrombus and pulmonary emboli (PE).

In October 2022, Medtronic Plc announced the launch of Medtronic Neurovascular Co-Lab(TM) Platform to accelerate innovation in stroke treatment. The platform will help bring neurovascular innovations to life. The process will be both transparent and collaborative, ensuring opportunities advance effectively and responsibly.

Key Questions Answered in This Report:

  • How has the global catheter-directed thrombolysis devices market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global catheter-directed thrombolysis devices market?
  • What is the impact of each driver, restraint, and opportunity on the global catheter-directed thrombolysis devices market?
  • What are the key regional markets?
  • Which countries represent the most attractive catheter-directed thrombolysis devices market?
  • What is the breakup of the market based on the delivery mode?
  • Which is the most attractive delivery mode in the catheter-directed thrombolysis devices market?
  • What is the breakup of the market based on the indication?
  • Which is the most attractive indication in the catheter-directed thrombolysis devices market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the catheter-directed thrombolysis devices market?
  • What is the competitive structure of the global catheter-directed thrombolysis devices market?
  • Who are the key players/companies in the global catheter-directed thrombolysis devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Catheter-Directed Thrombolysis Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Delivery Mode

  • 6.1 Directly Delivery to Blood Clot
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Positioning Medical Device at Clot Site
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Pulmonary Embolism (PE)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Deep Vein Thrombosis (DVT)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Stroke
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Others
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Germany
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 France
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 United Kingdom
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 Italy
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Spain
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Russia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Rest of Europe
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Asia-Pacific
    • 9.3.1 China
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 India
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 Japan
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Australia
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 South Korea
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Indonesia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Rest of Asia-Pacific
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Rest of Latin America
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AngioDynamics, Inc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT
    • 14.3.2 Boston Scientific Corporation
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT
    • 14.3.3 Inari Medical, Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 iVascular, S.L.U
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Medtronic Plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT
    • 14.3.6 Penumbra, Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Straub Medical AG (Becton, Dickinson and Company)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT
    • 14.3.8 Teleflex Incorporated
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT
    • 14.3.9 Thrombolex Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio

List of Figures

  • Figure 1: Global: Catheter-Directed Thrombolysis Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Catheter-Directed Thrombolysis Devices Market: Breakup by Delivery Mode (in %), 2023
  • Figure 4: Global: Catheter-Directed Thrombolysis Devices Market: Breakup by Indication (in %), 2023
  • Figure 5: Global: Catheter-Directed Thrombolysis Devices Market: Breakup by End User (in %), 2023
  • Figure 6: Global: Catheter-Directed Thrombolysis Devices Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 8: Global: Catheter-Directed Thrombolysis Devices (Directly delivery to blood clot) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Catheter-Directed Thrombolysis Devices (Directly delivery to blood clot) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Catheter-Directed Thrombolysis Devices (Positioning medical device at clot site) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Catheter-Directed Thrombolysis Devices (Positioning medical device at clot site) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Catheter-Directed Thrombolysis Devices (Pulmonary Embolism-PE) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Catheter-Directed Thrombolysis Devices (Pulmonary Embolism-PE) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Catheter-Directed Thrombolysis Devices (Deep Vein Thrombosis -DVT) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Catheter-Directed Thrombolysis Devices (Deep Vein Thrombosis -DVT) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Catheter-Directed Thrombolysis Devices (Stroke) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Catheter-Directed Thrombolysis Devices (Stroke) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Catheter-Directed Thrombolysis Devices (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Catheter-Directed Thrombolysis Devices (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Catheter-Directed Thrombolysis Devices (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Catheter-Directed Thrombolysis Devices (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Catheter-Directed Thrombolysis Devices (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Catheter-Directed Thrombolysis Devices (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: North America: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: North America: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: United States: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: United States: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Canada: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Canada: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Europe: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Europe: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Germany: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Germany: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: France: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: France: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: United Kingdom: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: United Kingdom: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Italy: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Italy: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Spain: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Spain: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Russia: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Russia: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Rest of Europe: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Rest of Europe: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia-Pacific: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia-Pacific: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: India: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: India: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Japan: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Japan: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Australia: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Australia: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: South Korea: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: South Korea: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Rest of Asia-Pacific: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Rest of Asia-Pacific: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Latin America: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Latin America: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Brazil: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Brazil: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Mexico: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Mexico: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Rest of Latin America: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Rest of Latin America: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Middle East and Africa: Catheter-Directed Thrombolysis Devices Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Middle East and Africa: Catheter-Directed Thrombolysis Devices Market: Breakup by Country (in %), 2023
  • Figure 72: Middle East and Africa: Catheter-Directed Thrombolysis Devices Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Global: Catheter-Directed Thrombolysis Devices Industry: SWOT Analysis
  • Figure 74: Global: Catheter-Directed Thrombolysis Devices Industry: Value Chain Analysis
  • Figure 75: Global: Catheter-Directed Thrombolysis Devices Industry: Porter's Five Forces Analysis
  • Figure 76: Global: Catheter-Directed Thrombolysis Devices Market: Breakup of Production Cost

List of Tables

  • Table 1: Global: Catheter-Directed Thrombolysis Devices Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Catheter-Directed Thrombolysis Devices Market: Breakup by Delivery Mode (in Million US$), 2018 & 2023
  • Table 3: Global: Catheter-Directed Thrombolysis Devices Market Forecast: Breakup by Delivery Mode (in Million US$), 2024-2032
  • Table 4: Global: Catheter-Directed Thrombolysis Devices Market: Breakup by Indication (in Million US$), 2018 & 2023
  • Table 5: Global: Catheter-Directed Thrombolysis Devices Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 6: Global: Catheter-Directed Thrombolysis Devices Market: Breakup by End User (in Million US$), 2018 & 2023
  • Table 7: Global: Catheter-Directed Thrombolysis Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 8: Global: Catheter-Directed Thrombolysis Devices Market: Breakup by Region (in Million US$), 2018 & 2023
  • Table 9: Global: Catheter-Directed Thrombolysis Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 10: Global: Catheter-Directed Thrombolysis Devices Industry: Key Price Indicators
  • Table 11: Global: Catheter-Directed Thrombolysis Devices Market: Competitive Structure
  • Table 12: Global: Catheter-Directed Thrombolysis Devices Market: Key Players